Dr. Qadan is a surgical oncologist and board-certified surgical specialist at Massachusetts General Hospital. He is a clinical lead for Phase III trials of Halozyme's pancreatic cancer drug PEGPH20. He also serves as an Assistant Professor of Surgery at Harvard Medical School.
